Published in Cell on November 13, 1992
Hepatitis B virus biology. Microbiol Mol Biol Rev (2000) 7.58
Novel mechanism for reverse transcription in hepatitis B viruses. J Virol (1993) 4.47
Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis. J Virol (1994) 3.05
Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer. J Virol (1994) 2.98
Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc Natl Acad Sci U S A (1996) 2.97
De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus. J Virol (2000) 2.65
Hepatitis B virus replication. World J Gastroenterol (2007) 2.30
Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription. J Virol (1994) 2.10
A bulged region of the hepatitis B virus RNA encapsidation signal contains the replication origin for discontinuous first-strand DNA synthesis. J Virol (1996) 2.07
Identification of a new, abundant superfamily of mammalian LTR-transposons. Nucleic Acids Res (1993) 2.04
Analysis of the earliest steps of hepadnavirus replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity. J Virol (1993) 1.89
Role of RNA in enzymatic activity of the reverse transcriptase of hepatitis B viruses. J Virol (1994) 1.87
Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidine. Antimicrob Agents Chemother (1995) 1.85
Nucleotide priming and reverse transcriptase activity of hepatitis B virus polymerase expressed in insect cells. J Virol (1995) 1.83
Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation. J Virol (2007) 1.80
Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus. J Virol (1994) 1.78
Expression of functional hepatitis B virus polymerase in yeast reveals it to be the sole viral protein required for correct initiation of reverse transcription. Proc Natl Acad Sci U S A (1993) 1.77
Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function. J Virol (2004) 1.72
A novel mechanism of self-primed reverse transcription defines a new family of retroelements. Mol Cell Biol (1995) 1.64
Evidence for activation of the hepatitis B virus polymerase by binding of its RNA template. J Virol (1996) 1.64
Terminal proteins essential for the replication of linear plasmids and chromosomes in Streptomyces. Genes Dev (2001) 1.53
Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G. J Virol (2007) 1.52
In vitro reconstitution of a functional duck hepatitis B virus reverse transcriptase: posttranslational activation by Hsp90. J Virol (2000) 1.52
Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein. J Virol (2007) 1.51
Transcomplementation of nucleotide priming and reverse transcription between independently expressed TP and RT domains of the hepatitis B virus reverse transcriptase. J Virol (1997) 1.50
Specific hepatitis B virus minus-strand DNA synthesis requires only the 5' encapsidation signal and the 3'-proximal direct repeat DR1. J Virol (1996) 1.49
In vitro reconstitution of functional hepadnavirus reverse transcriptase with cellular chaperone proteins. J Virol (2002) 1.49
The duck hepatitis B virus polymerase is activated by its RNA packaging signal, epsilon. J Virol (1998) 1.48
Molecular biology of hepatitis B virus infection. Virology (2015) 1.47
Hepatitis B virus DNA replication is coordinated by core protein serine phosphorylation and HBx expression. J Virol (2005) 1.47
Replication infidelity during a single cycle of Ty1 retrotransposition. Proc Natl Acad Sci U S A (1996) 1.45
cis-Acting sequences in addition to donor and acceptor sites are required for template switching during synthesis of plus-strand DNA for duck hepatitis B virus. J Virol (1997) 1.44
Transfer of the minus strand of DNA during hepadnavirus replication is not invariable but prefers a specific location. J Virol (1995) 1.43
Full-length hepatitis B virus core protein packages viral and heterologous RNA with similarly high levels of cooperativity. J Virol (2010) 1.41
Conditional replication of duck hepatitis B virus in hepatoma cells. J Virol (2003) 1.39
Guanylylation and adenylylation of the alpha regulatory proteins of herpes simplex virus require a viral beta or gamma function. J Virol (1993) 1.37
The importance of the A-rich loop in human immunodeficiency virus type 1 reverse transcription and infectivity. J Virol (1997) 1.37
Hepatitis B virus reverse transcriptase and epsilon RNA sequences required for specific interaction in vitro. J Virol (2006) 1.36
In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir. Antimicrob Agents Chemother (1998) 1.36
Binding and kinetic properties of HIV-1 reverse transcriptase markedly differ during initiation and elongation of reverse transcription. EMBO J (1996) 1.36
Group II intron mobility using nascent strands at DNA replication forks to prime reverse transcription. EMBO J (2003) 1.35
An unusual mechanism of self-primed reverse transcription requires the RNase H domain of reverse transcriptase to cleave an RNA duplex. Mol Cell Biol (1996) 1.33
Formation of a functional hepatitis B virus replication initiation complex involves a major structural alteration in the RNA template. Mol Cell Biol (1998) 1.30
Molecular virology of hepatitis B virus for clinicians. Clin Liver Dis (2007) 1.28
Reconstitution of a functional duck hepatitis B virus replication initiation complex from separate reverse transcriptase domains expressed in Escherichia coli. J Virol (2001) 1.23
Selected mutations of the duck hepatitis B virus P gene RNase H domain affect both RNA packaging and priming of minus-strand DNA synthesis. J Virol (1994) 1.22
Regulation of hepadnavirus reverse transcription by dynamic nucleocapsid phosphorylation. J Virol (2006) 1.21
RNA sequences controlling the initiation and transfer of duck hepatitis B virus minus-strand DNA. J Virol (1995) 1.20
Mapping of the hepatitis B virus reverse transcriptase TP and RT domains by transcomplementation for nucleotide priming and by protein-protein interaction. J Virol (1999) 1.20
Sequence- and structure-specific determinants in the interaction between the RNA encapsidation signal and reverse transcriptase of avian hepatitis B viruses. J Virol (1997) 1.19
Hepatitis B virus-cell interactions and pathogenesis. J Cell Physiol (2008) 1.17
In vivo RNA-directed transcription, with template switching, by a mammalian RNA polymerase. EMBO J (2002) 1.16
Recombinant human hepatitis B virus reverse transcriptase is active in the absence of the nucleocapsid or the viral replication origin, DR1. J Virol (1993) 1.14
Base pairing between the 5' half of epsilon and a cis-acting sequence, phi, makes a contribution to the synthesis of minus-strand DNA for human hepatitis B virus. J Virol (2006) 1.12
Base pairing among three cis-acting sequences contributes to template switching during hepadnavirus reverse transcription. Proc Natl Acad Sci U S A (2003) 1.12
Overlapping initiator and TATA box functions in the basal core promoter of hepatitis B virus. J Virol (1995) 1.12
Duck hepatitis B virus nucleocapsids formed by N-terminally extended or C-terminally truncated core proteins disintegrate during viral DNA maturation. J Virol (1998) 1.12
Base pairing between cis-acting sequences contributes to template switching during plus-strand DNA synthesis in human hepatitis B virus. J Virol (2007) 1.11
Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway. J Virol (2007) 1.10
Functional characterization of naturally occurring variants of human hepatitis B virus containing the core internal deletion mutation. J Virol (1998) 1.10
The arginine clusters of the carboxy-terminal domain of the core protein of hepatitis B virus make pleiotropic contributions to genome replication. J Virol (2010) 1.09
The carbocyclic analog of 2'-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver. J Virol (1994) 1.08
Human hepatitis B virus polymerase interacts with the molecular chaperonin Hsp60. J Virol (2001) 1.08
cis-Acting sequences that contribute to the synthesis of relaxed-circular DNA of human hepatitis B virus. J Virol (2004) 1.08
Avian hepatitis B viruses: molecular and cellular biology, phylogenesis, and host tropism. World J Gastroenterol (2007) 1.08
Mutations within DR2 independently reduce the amount of both minus- and plus-strand DNA synthesized during duck hepatitis B virus replication. J Virol (1996) 1.07
Heat shock protein 90-independent activation of truncated hepadnavirus reverse transcriptase. J Virol (2003) 1.07
Chaperones activate hepadnavirus reverse transcriptase by transiently exposing a C-proximal region in the terminal protein domain that contributes to epsilon RNA binding. J Virol (2007) 1.06
Generation of replication-competent hepatitis B virus nucleocapsids in insect cells. J Virol (1998) 1.06
Chaperone activation of the hepadnaviral reverse transcriptase for template RNA binding is established by the Hsp70 and stimulated by the Hsp90 system. Nucleic Acids Res (2007) 1.05
Serine phosphoacceptor sites within the core protein of hepatitis B virus contribute to genome replication pleiotropically. PLoS One (2011) 1.05
Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes. PLoS Pathog (2013) 1.04
A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency. J Virol (2001) 1.03
Evidence that the 5'-end cap structure is essential for encapsidation of hepatitis B virus pregenomic RNA. J Virol (2000) 1.03
Small DNA hairpin negatively regulates in situ priming during duck hepatitis B virus reverse transcription. J Virol (2002) 1.03
A sensitive procedure for mapping the boundaries of RNA elements binding in vitro translated proteins defines a minimal hepatitis B virus encapsidation signal. Nucleic Acids Res (1996) 1.02
Reverse transcriptase activity innate to DNA polymerase I and DNA topoisomerase I proteins of Streptomyces telomere complex. Proc Natl Acad Sci U S A (2004) 1.01
A SELEX-screened aptamer of human hepatitis B virus RNA encapsidation signal suppresses viral replication. PLoS One (2011) 1.00
SELEX-derived aptamers of the duck hepatitis B virus RNA encapsidation signal distinguish critical and non-critical residues for productive initiation of reverse transcription. Nucleic Acids Res (2004) 1.00
Detection of DNA polymerase activities associated with purified duck hepatitis B virus core particles by using an activity gel assay. J Virol (1993) 1.00
Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids. J Virol (2013) 0.99
In vitro epsilon RNA-dependent protein priming activity of human hepatitis B virus polymerase. J Virol (2012) 0.99
Distinct requirements for primary sequence in the 5'- and 3'-part of a bulge in the hepatitis B virus RNA encapsidation signal revealed by a combined in vivo selection/in vitro amplification system. Nucleic Acids Res (1995) 0.98
Identification of an essential molecular contact point on the duck hepatitis B virus reverse transcriptase. J Virol (2005) 0.97
The topology of hepatitis B virus pregenomic RNA promotes its replication. J Virol (2007) 0.97
Inhibitory effect of 2'-fluoro-5-methyl-beta-L-arabinofuranosyl-uracil on duck hepatitis B virus replication. Antimicrob Agents Chemother (1998) 0.95
Priming of duck hepatitis B virus reverse transcription in vitro: premature termination of primer DNA induced by the 5'-triphosphate of fialuridine. J Virol (1994) 0.95
RNA-protein interactions in hepadnavirus reverse transcription. Front Biosci (Landmark Ed) (2009) 0.95
2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo. Antimicrob Agents Chemother (1996) 0.95
Inhibition of hepadnavirus reverse transcriptase-epsilon RNA interaction by porphyrin compounds. J Virol (2007) 0.94
Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics. Antiviral Res (2015) 0.94
Functional and structural dynamics of hepadnavirus reverse transcriptase during protein-primed initiation of reverse transcription: effects of metal ions. J Virol (2008) 0.93
dNTP versus NTP discrimination by phenylalanine 451 in duck hepatitis B virus P protein indicates a common structure of the dNTP-binding pocket with other reverse transcriptases. Nucleic Acids Res (2002) 0.93
Distinct requirement for two stages of protein-primed initiation of reverse transcription in hepadnaviruses. J Virol (2002) 0.93
Core protein: A pleiotropic keystone in the HBV lifecycle. Antiviral Res (2015) 0.93
A novel cis-acting element facilitates minus-strand DNA synthesis during reverse transcription of the hepatitis B virus genome. J Virol (2004) 0.92
Effects of genomic length on translocation of hepatitis B virus polymerase-linked oligomer. J Virol (2000) 0.92
A host factor that binds near the termini of hepatitis B virus pregenomic RNA. J Virol (1996) 0.91
A Tyr residue in the reverse transcriptase domain can mimic the protein-priming Tyr residue in the terminal protein domain of a hepadnavirus P protein. J Virol (2011) 0.91
Effect of alpha interferon on the hepatitis C virus replicon. J Virol (2001) 6.18
Novel mechanism for reverse transcription in hepatitis B viruses. J Virol (1993) 4.47
Biochemical and genetic evidence for the hepatitis B virus replication strategy. Science (1986) 4.12
Nucleotide sequence of an infectious molecularly cloned genome of ground squirrel hepatitis virus. J Virol (1984) 3.91
Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol (1994) 3.34
Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc Natl Acad Sci U S A (1996) 2.97
Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids. EMBO J (1997) 2.91
Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother (1997) 2.84
Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J Virol (1994) 2.69
Role of RNA in enzymatic activity of the reverse transcriptase of hepatitis B viruses. J Virol (1994) 1.87
Closed circular viral DNA and asymmetrical heterogeneous forms in livers from animals infected with ground squirrel hepatitis virus. J Virol (1983) 1.79
Replication of DHBV genomes with mutations at the sites of initiation of minus- and plus-strand DNA synthesis. Virology (1992) 1.77
Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections. J Virol (2000) 1.73
The cloned genome of ground squirrel hepatitis virus is infectious in the animal. Proc Natl Acad Sci U S A (1984) 1.60
Differential activation of myc gene family members in hepatic carcinogenesis by closely related hepatitis B viruses. Mol Cell Biol (1993) 1.38
In vitro infection of woodchuck hepatocytes with woodchuck hepatitis virus and ground squirrel hepatitis virus. Virology (1989) 1.34
In vitro recombinants of ground squirrel and woodchuck hepatitis viral DNAs produce infectious virus in squirrels. J Virol (1987) 1.20
Expression and characterization of hepadnavirus reverse transcriptases. Methods Enzymol (1996) 1.12
Does a cdc2 kinase-like recognition motif on the core protein of hepadnaviruses regulate assembly and disintegration of capsids? J Virol (2001) 0.99
Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections. J Virol (2000) 0.99
[Immune reactions to posterior lamellar versus penetrating keratoplasty. A retrospective analysis]. Ophthalmologe (2012) 0.77
Beat-to-beat variation of heart rate in diabetic patients with autonomic neuropathy and in completely cardiac denervated patients following orthotopic heart transplantation. Int J Cardiol (1991) 0.75
[Experimental models for the study of hepadnaviruses and antiviral strategies]. Gastroenterol Clin Biol (1995) 0.75